Business Description
Sino Biological Inc
ISIN : CNE100004Q23
Share Class Description:
SZSE:301047: Class ACompare
Compare
Traded in other countries / regions
301047.China IPO Date
2021-08-16Description
Sino Biological Inc is an international reagent supplier and service provider. The company specializes in recombinant protein production and antibody development. All of Sino Biological's products are independently developed and produced, including recombinant proteins, antibodies and cDNA clones.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 56.54 | |||||
| Equity-to-Asset | 0.96 | |||||
| Debt-to-Equity | 0.01 | |||||
| Debt-to-EBITDA | 0.39 | |||||
| Interest Coverage | 20.78 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 18.16 | |||||
| Beneish M-Score | -2.43 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -32.8 | |||||
| 3-Year EBITDA Growth Rate | -41.7 | |||||
| 3-Year EPS without NRI Growth Rate | -44.3 | |||||
| 3-Year Book Growth Rate | 54.3 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 28.03 | |||||
| 9-Day RSI | 30.75 | |||||
| 14-Day RSI | 36.87 | |||||
| 6-1 Month Momentum % | 10.04 | |||||
| 12-1 Month Momentum % | -17.09 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 22.68 | |||||
| Quick Ratio | 22.33 | |||||
| Cash Ratio | 21.22 | |||||
| Days Inventory | 145.9 | |||||
| Days Sales Outstanding | 87.69 | |||||
| Days Payable | 43.18 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 3.14 | |||||
| Dividend Payout Ratio | 1.67 | |||||
| Forward Dividend Yield % | 3.14 | |||||
| 5-Year Yield-on-Cost % | 3.14 | |||||
| 3-Year Average Share Buyback Ratio | -10.1 | |||||
| Shareholder Yield % | 3 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 77.06 | |||||
| Operating Margin % | 14.47 | |||||
| Net Margin % | 24.28 | |||||
| FCF Margin % | 25.96 | |||||
| ROE % | 2.51 | |||||
| ROA % | 2.41 | |||||
| ROIC % | 4.62 | |||||
| ROC (Joel Greenblatt) % | 17.51 | |||||
| ROCE % | 2.82 | |||||
| Years of Profitability over Past 10-Year | 7 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 53.14 | |||||
| Forward PE Ratio | 20.69 | |||||
| PE Ratio without NRI | 53.14 | |||||
| PS Ratio | 12.84 | |||||
| PB Ratio | 1.4 | |||||
| Price-to-Tangible-Book | 1.48 | |||||
| Price-to-Free-Cash-Flow | 49.77 | |||||
| Price-to-Operating-Cash-Flow | 37.09 | |||||
| EV-to-EBIT | 22.03 | |||||
| EV-to-Forward-EBIT | 38.05 | |||||
| EV-to-EBITDA | 22.03 | |||||
| EV-to-Forward-EBITDA | 37.48 | |||||
| EV-to-Revenue | 6.1 | |||||
| EV-to-Forward-Revenue | 9.04 | |||||
| EV-to-FCF | 23.99 | |||||
| Price-to-Graham-Number | 1.87 | |||||
| Price-to-Net-Current-Asset-Value | 2.06 | |||||
| Price-to-Net-Cash | 2.21 | |||||
| Earnings Yield (Greenblatt) % | 4.54 | |||||
| FCF Yield % | 2.13 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Sino Biological Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 635.277 | ||
| EPS (TTM) (Â¥) | 1.199 | ||
| Beta | 1.87 | ||
| Volatility % | 49.13 | ||
| 14-Day RSI | 36.87 | ||
| 14-Day ATR (Â¥) | 1.574467 | ||
| 20-Day SMA (Â¥) | 66.4845 | ||
| 12-1 Month Momentum % | -17.09 | ||
| 52-Week Range (Â¥) | 53.51 - 89.09 | ||
| Shares Outstanding (Mil) | 121.64 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Sino Biological Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Sino Biological Inc Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Sino Biological Inc Frequently Asked Questions
What is Sino Biological Inc(SZSE:301047)'s stock price today?
The current price of SZSE:301047 is ¥63.71. The 52 week high of SZSE:301047 is ¥89.09 and 52 week low is ¥53.51.
When is next earnings date of Sino Biological Inc(SZSE:301047)?
The next earnings date of Sino Biological Inc(SZSE:301047) is .
Does Sino Biological Inc(SZSE:301047) pay dividends? If so, how much?
The Dividend Yield %  of Sino Biological Inc(SZSE:301047) is 3.14% (As of Today), Highest Dividend Payout Ratio of Sino Biological Inc(SZSE:301047) was 3.76. The lowest was 0.99. And the median was 2.38. The  Forward Dividend Yield % of Sino Biological Inc(SZSE:301047) is 3.14%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers